MS Research Update 2019 - annual publica... - My MSAA Community

My MSAA Community

9,019 members20,711 posts

MS Research Update 2019 - annual publication from MSAA

johnMSAA profile image
johnMSAAPartner
2 Replies

MSAA’s 2019 edition of the "MS Research Update" is out now! This important publication provides a comprehensive overview of the study results on many of the approved and experimental disease-modifying therapies (DMTs) for multiple sclerosis.

In addition to medications, the update also highlights new directions in research – including:

* Diet

* Vitamin D, biotin

* Gut microbiome

* Stem cells, genetics

* Biomarkers

MSAA’s MS Research Update offers the latest data available (** PLEASE NOTE: as of April 2019 **), including the two recent FDA approvals of medications that for the first time can treat active secondary-progressive MS. It also features a helpful chart of the approved disease-modifying therapies – providing a quick and easy way to compare details on administration, dose, and side effects.

The 2019 edition of MSAA’s MS Research Update may be viewed as a digital edition that allows for easier reading and navigation through the different sections:

* Interactive Digital Edition:

mymsaa.org/publications/msr...

...as well as a PDF, and a web version:

* View in HTML on MSAA's website or download the PDF:

mymsaa.org/publications/msr...

We do also have a VERY limited run of print copies to order; however, due to this small print run, we suggest that you read either online version and/or download the PDF that you can then print at home or elsewhere.

Thank you!

- John, MSAA

Written by
johnMSAA profile image
johnMSAA
Partner
To view profiles and participate in discussions please or .
Read more about...
2 Replies
greaterexp profile image
greaterexp

Thank you!

bxrmom profile image
bxrmom

Thanks so much for sharing!

Jessie

You may also like...

NEW from MSAA: The Ultimate MS Treatment Guide

about the different FDA-approved disease-modifying therapies. Developed by MSAA in collaboration...

What’s New in MS Research: Highlights from the 2018 ECTRIMS Annual Meeting

this in an email today, interesting: https://mymsaa.org/news/2018-ectrims-annual-meeting/?utm_source

Ocrevus: FDA Approves First Drug to Treat Two Forms of MS

either an approved disease-modifying therapy or a placebo.\\" For more on Ocrevus, you can read...

Glatopa: FDA Approves Three-Times Weekly Dose

fully-substitutable generic version of Copaxone®, a disease-modifying therapy (DMT) approved for...

MAY 2018 MSAA MS Ability Art Showcase Artist of the Month

and the freedom painting provides me with. I’m incredibly grateful to MSAA for being champions for...